CD81 and acute myeloid leukemia: These results could be explained by the finding of Boyer et al., who demonstrated that CD81-positive malignant cells were 30-50% more resistant to drugs and that overexpression of CD81 increased AML cell adhesion, which induced blast number and caused relapses [17].